Sacrosidase
- Atc Codes:A16AB06
- CAS Codes:85897-35-4
- PHARMGKB ID:85897-35-4
Table of contents
- Brand Names
- Chemistry
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Caution and personalized dose adjustment in patients with the following genotypes
- Drug Interactions
- Nutrition/Nutraceutical Interactions
- Dosage
- Pharmacokinetics and Pharmacodynamics
- Special Considerations
Brand Names
North America
USA: Sucraid.
Drug combinations
Chemistry
Sacrosidase: Mw: approx. 140000.01. β-Fructofuranosidase (Saccharomyces cerevisiae clone FI4 protein moiety reduced). CAS-85897-35-4 (1997).
Pharmacologic Category
Enzymes. (ATC-Code: A16AB06).
Mechanism of action
A naturally-occurring GI enzyme which breaks down disaccharide sucrose to its monosaccharide components (glucose and fructose).
Therapeutic use
Sucrase deficiency (congenital sucrase-isomaltase deficiency).
Pregnancy and lactiation implications
Animal studies not conducted. Should be administered to a pregnant woman only when indicated. Enters breast milk (compatible with lactation).
Unlabeled use
Contraindications
Hypersensitivity to yeast, yeast products, or glycerin.
Warnings and precautions
Hypersensitivity reactions to sacrosidase, including bronchospasm, reported. Product may contain papain (risk of severe hypersensitivity reactions).